This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schirmbeck, R. Articles by Reimann, J. Search for Related Content PubMed PubMed Citation Articles by Schirmbeck, R. Articles by Reimann, J.

Next Article 

J. Virol., Oct 1995, 5929-5934, Vol 69, No. 10
Copyright © 1995, American Society for Microbiology

Nucleic acid vaccination primes hepatitis B virus surface antigen- specific cytotoxic T lymphocytes in nonresponder mice

R Schirmbeck, W Bohm, K Ando, FV Chisari and J Reimann
Institute of Medical Microbiology, University of Ulm, Germany.

The efficiency of different vaccination techniques to prime in vivo major histocompatibility complex class I-restricted murine cytotoxic T- lymphocyte (CTL) precursors to hepatitis B virus small surface antigen (HBsAg) was investigated. Mice were immunized either by injection of a low dose of recombinant HBsAg protein preparations (native HBsAg particles or denatured HBsAg monomers) without adjuvants, by infection with recombinant vaccinia virus carrying an HBsAg-encoding gene, or by intramuscular transfer of plasmid DNA encoding HBsAg under appropriate promoter control. In H-2d mice, an Ld-restricted, S28-39-specific CTL response was efficiently primed by all alternative vaccination techniques tested, but the most potent priming of class I-restricted CTL to HBsAg in vivo was observed with DNA immunization. Priming of anti-HBsAg CTL in H-2b mice was not detectable after infection with a recombinant vaccinia virus or after injection with exogenous recombinant HBsAg preparations. After DNA immunization, however, both Kb- and Db-restricted CTL reactivity to HBsAg emerged in H-2b mice. Hence, nucleic acid immunization revealed class I-restricted CTL responsiveness to HBsAg in a mouse strain previously considered to be a nonresponder at the CTL level. These results demonstrate that the simple technique of nucleic acid immunization not only is extremely efficient but also reveals an extended spectrum of potentially immunogenic epitopes of protein antigens.

This article has been cited by other articles:

• Ito, H., Ando, K., Ishikawa, T., Nakayama, T., Taniguchi, M., Saito, K., Imawari, M., Moriwaki, H., Yokochi, T., Kakumu, S., Seishima, M. (2008). Role of V{alpha}14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of V{alpha}14+ NKT cells promotes the breakage of CTL tolerance. Int Immunol 20: 869-879 [Abstract] [Full Text]  
• Yang, K., Whalen, B. J., Tirabassi, R. S., Selin, L. K., Levchenko, T. S., Torchilin, V. P., Kislauskis, E. H., Guberski, D. L. (2008). A DNA Vaccine Prime Followed by a Liposome-Encapsulated Protein Boost Confers Enhanced Mucosal Immune Responses and Protection. J. Immunol. 180: 6159-6167 [Abstract] [Full Text]  
• Schirmbeck, R., Riedl, P., Kupferschmitt, M., Wegenka, U., Hauser, H., Rice, J., Kroger, A., Reimann, J. (2006). Priming Protective CD8 T Cell Immunity by DNA Vaccines Encoding Chimeric, Stress Protein-Capturing Tumor-Associated Antigen. J. Immunol. 177: 1534-1542 [Abstract] [Full Text]  
• Woo, W.-P., Doan, T., Herd, K. A., Netter, H.-J., Tindle, R. W. (2006). Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.. J. Virol. 80: 3975-3984 [Abstract] [Full Text]  
• Riedl, P., Bertoletti, A., Lopes, R., Lemonnier, F., Reimann, J., Schirmbeck, R. (2006). Distinct, Cross-Reactive Epitope Specificities of CD8 T Cell Responses Are Induced by Natural Hepatitis B Surface Antigen Variants of Different Hepatitis B Virus Genotypes. J. Immunol. 176: 4003-4011 [Abstract] [Full Text]  
• Hutchings, C. L., Gilbert, S. C., Hill, A. V. S., Moore, A. C. (2005). Novel Protein and Poxvirus-Based Vaccine Combinations for Simultaneous Induction of Humoral and Cell-Mediated Immunity. J. Immunol. 175: 599-606 [Abstract] [Full Text]  
• Lu, M., Isogawa, M., Xu, Y., Hilken, G. (2005). Immunization with the Gene Expressing Woodchuck Hepatitis Virus Nucleocapsid Protein Fused to Cytotoxic-T-Lymphocyte-Associated Antigen 4 Leads to Enhanced Specific Immune Responses in Mice and Woodchucks. J. Virol. 79: 6368-6376 [Abstract] [Full Text]  
• Kirby, A. C., Sundquist, M., Wick, M. J. (2004). In Vivo Compartmentalization of Functionally Distinct, Rapidly Responsive Antigen-Specific T-Cell Populations in DNA-Immunized or Salmonella enterica Serovar Typhimurium-Infected Mice. Infect. Immun. 72: 6390-6400 [Abstract] [Full Text]  
• Schirmbeck, R., Riedl, P., Zurbriggen, R., Akira, S., Reimann, J. (2003). Antigenic Epitopes Fused to Cationic Peptide Bound to Oligonucleotides Facilitate Toll-Like Receptor 9-Dependent, but CD4+ T Cell Help-Independent, Priming of CD8+ T Cells. J. Immunol. 171: 5198-5207 [Abstract] [Full Text]  
• Srivastava, I. K., Liu, M. A. (2003). Gene Vaccines. ANN INTERN MED 138: 550-559 [Abstract] [Full Text]  
• Kasahara, S., Ando, K., Saito, K., Sekikawa, K., Ito, H., Ishikawa, T., Ohnishi, H., Seishima, M., Kakumu, S., Moriwaki, H. (2003). Lack of Tumor Necrosis Factor Alpha Induces Impaired Proliferation of Hepatitis B Virus-Specific Cytotoxic T Lymphocytes. J. Virol. 77: 2469-2476 [Abstract] [Full Text]  
• Pilling, A. M., Harman, R. M., Jones, S. A., Mccormack, N. A.M., Lavender, D., Haworth, R. (2002). The Assessment of Local Tolerance, Acute Toxicity, and DNA Biodistribution Following Particle-Mediated Delivery of a DNA Vaccine to Minipigs. Toxicol Pathol 30: 298-305 [Abstract]  
• Malanchere-Bres, E., Payette, P. J., Mancini, M., Tiollais, P., Davis, H. L., Michel, M.-L. (2001). CpG Oligodeoxynucleotides with Hepatitis B Surface Antigen (HBsAg) for Vaccination in HBsAg-Transgenic Mice. J. Virol. 75: 6482-6491 [Abstract] [Full Text]  
• Chen, S.-A., Wu, M.-H. T. F.-T., Hsiang, A., Chen, Y.-L., Lei, H.-Y., Tzai, T.-S., Leung, H. W. C., Jin, Y.-T., Hsieh, C.-L., Hwang, L.-H., Lai, M.-D. (2000). Induction of Antitumor Immunity with Combination of HER2/neu DNA Vaccine and Interleukin 2 Gene-modified Tumor Vaccine. Clin. Cancer Res. 6: 4381-4388 [Abstract] [Full Text]  
• Ohashi, T., Hanabuchi, S., Kato, H., Tateno, H., Takemura, F., Tsukahara, T., Koya, Y., Hasegawa, A., Masuda, T., Kannagi, M. (2000). Prevention of Adult T-Cell Leukemia-Like Lymphoproliferative Disease in Rats by Adoptively Transferred T Cells from a Donor Immunized with Human T-Cell Leukemia Virus Type 1 Tax-Coding DNA Vaccine. J. Virol. 74: 9610-9616 [Abstract] [Full Text]  
• Flesch, I. E. A., Stober, D., Schirmbeck, R., Reimann, J. (2000). Monocyte inflammatory protein-1{alpha} facilitates priming of CD8+ T cell responses to exogenous viral antigen. Int Immunol 12: 1365-1370 [Abstract] [Full Text]  
• Schirmbeck, R., Wild, J., Stober, D., Blum, H. E., Chisari, F. V., Geissler, M., Reimann, J. (2000). Ongoing Murine T1 or T2 Immune Responses to the Hepatitis B Surface Antigen Are Excluded from the Liver that Expresses Transgene-Encoded Hepatitis B Surface Antigen. J. Immunol. 164: 4235-4243 [Abstract] [Full Text]  
• Fensterle, J., Grode, L., Hess, J., Kaufmann, S. H. E. (1999). Effective DNA Vaccination Against Listeriosis by Prime/Boost Inoculation with the Gene Gun. J. Immunol. 163: 4510-4518 [Abstract] [Full Text]  
• Wild, J., Grusby, M. J., Schirmbeck, R., Reimann, J. (1999). Priming MHC-I-Restricted Cytotoxic T Lymphocyte Responses to Exogenous Hepatitis B Surface Antigen Is CD4+ T Cell Dependent. J. Immunol. 163: 1880-1887 [Abstract] [Full Text]  
• Schirmbeck, R., Melber, K., Reimann, J. (1999). Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen. Int Immunol 11: 1093-1102 [Abstract] [Full Text]  
• Abuodeh, R. O., Shubitz, L. F., Siegel, E., Snyder, S., Peng, T., Orsborn, K. I., Brummer, E., Stevens, D. A., Galgiani, J. N. (1999). Resistance to Coccidioides immitis in Mice after Immunization with Recombinant Protein or a DNA Vaccine of a Proline-Rich Antigen. Infect. Immun. 67: 2935-2940 [Abstract] [Full Text]  
• Geissler, M., Bruss, V., Michalak, S., Hockenjos, B., Ortmann, D., Offensperger, W. B., Wands, J. R., Blum, H. E. (1999). Intracellular Retention of Hepatitis B Virus Surface Proteins Reduces Interleukin-2 Augmentation after Genetic Immunizations. J. Virol. 73: 4284-4292 [Abstract] [Full Text]  
• Lu, M., Hilken, G., Kruppenbacher, J., Kemper, T., Schirmbeck, R., Reimann, J., Roggendorf, M. (1999). Immunization of Woodchucks with Plasmids Expressing Woodchuck Hepatitis Virus (WHV) Core Antigen and Surface Antigen Suppresses WHV Infection. J. Virol. 73: 281-289 [Abstract] [Full Text]  
• Mancini, M., Hadchouel, M., Tiollais, P., Michel, M.-L. (1998). Regulation of Hepatitis B Virus mRNA Expression in a Hepatitis B Surface Antigen Transgenic Mouse Model by IFN-{gamma}-Secreting T Cells After DNA-Based Immunization. J. Immunol. 161: 5564-5570 [Abstract] [Full Text]  
• Shimizu, Y., Guidotti, L. G., Fowler, P., Chisari, F. V. (1998). Dendritic Cell Immunization Breaks Cytotoxic T Lymphocyte Tolerance in Hepatitis B Virus Transgenic Mice. J. Immunol. 161: 4520-4529 [Abstract] [Full Text]  
• Henke, A., Wagner, E., Whitton, J. L., Zell, R., Stelzner, A. (1998). Protection of Mice against Lethal Coxsackievirus B3 Infection by Using DNA Immunization. J. Virol. 72: 8327-8331 [Abstract] [Full Text]  
• Bohm, W., Thoma, S., Leithauser, F., Moller, P., Schirmbeck, R., Reimann, J. (1998). T Cell-Mediated, IFN-{gamma}-Facilitated Rejection of Murine B16 Melanomas. J. Immunol. 161: 897-908 [Abstract] [Full Text]  
• Andre, S., Seed, B., Eberle, J., Schraut, W., Bultmann, A., Haas, J. (1998). Increased Immune Response Elicited by DNA Vaccination with a Synthetic gp120 Sequence with Optimized Codon Usage. J. Virol. 72: 1497-1503 [Abstract] [Full Text]  
• Chow, Y.-H., Chiang, B.-L., Lee, Y.-L., Chi, W.-K., Lin, W.-C., Chen, Y.-T., Tao, M.-H. (1998). Development of Th1 and Th2 Populations and the Nature of Immune Responses to Hepatitis B Virus DNA Vaccines Can Be Modulated by Codelivery of Various Cytokine Genes. J. Immunol. 160: 1320-1329 [Abstract] [Full Text]  
• Triyatni, M., Jilbert, A. R., Qiao, M., Miller, D. S., Burrell, C. J. (1998). Protective Efficacy of DNA Vaccines against Duck Hepatitis B Virus Infection. J. Virol. 72: 84-94 [Abstract] [Full Text]